Open Access
Short Note
Issue
Parasite
Volume 27, 2020
Article Number 2
Number of page(s) 4
DOI https://doi.org/10.1051/parasite/2019080
Published online 14 January 2020
  • Benard A, Petersen E, Salamon R, Chene G, Gilbert R, Salmi LR, European Toxo Prevention Study G. 2008. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveillance, 13(15). [Google Scholar]
  • Berger F, Goulet V, Le Strat Y, Desenclos JC. 2009. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Revue d’Epidemiologie et de Sante Publique, 57(4), 241–248. [CrossRef] [Google Scholar]
  • Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, Ades AE. 1996. Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiology and Infection, 116(3), 347–351. [CrossRef] [PubMed] [Google Scholar]
  • Canessa A, Pantarotto F, Miletich F, Russo A, Gotta C, Bozzuffi PM, Ferrari G, Fiorelli A, Terragna A. 1987. Antibody prevalence to torch agents in pregnant women and relative risk of congenital infections in Italy (Liguria). Biological Research in Pregnancy and Perinatology, 8(2 2D Half), 84–88. [PubMed] [Google Scholar]
  • Capretti MG, De Angelis M, Tridapalli E, Orlandi A, Marangoni A, Moroni A, Guerra B, Arcuri S, Marsico C, Faldella G. 2014. Toxoplasmosis in pregnancy in an area with low seroprevalence: is prenatal screening still worthwhile? The Pediatric Infectious Disease Journal, 33(1), 5–10. [CrossRef] [PubMed] [Google Scholar]
  • Condorelli F, Scalia G, Stivala A, Costanzo MC, Adragna AD, Franceschino C, Santagati MG, Furneri PM, Marino A, Castro A. 1993. Seroprevalence to some TORCH agents in a Sicilian female population of fertile age. European Journal of Epidemiology, 9(3), 341–343. [CrossRef] [PubMed] [Google Scholar]
  • Dalmartello M, Parazzini F, Pedron M, Pertile R, Collini L, La Vecchia C, Piffer S. 2019. Coverage and outcomes of antenatal tests for infections: a population based survey in the Province of Trento, Italy. Journal of Maternal-Fetal and Neonatal Medicine, 32(12), 2049–2055. [CrossRef] [Google Scholar]
  • De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT, Cavallari S, Vigano EF. 2008. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clinical Microbiology and Infection, 14(2), 186–189. [CrossRef] [Google Scholar]
  • Diza E, Frantzidou F, Souliou E, Arvanitidou M, Gioula G, Antoniadis A. 2005. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clinical Microbiology and Infection, 11(9), 719–723. [CrossRef] [Google Scholar]
  • Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. The Lancet, 353(9167), 1829–1833. [CrossRef] [PubMed] [Google Scholar]
  • Ferrucci M, Dall’Ara G. 1980. Immunological indexes of receptivity and seroconversion for rubella and toxoplasmosis in the province of Ferrara, Italy (author’s transl). Annali Sclavo, 22(4), 606–623. [Google Scholar]
  • Havelaar AH, Kemmeren JM, Kortbeek LM. 2007. Disease burden of congenital toxoplasmosis. Clinical Infectious Diseases, 44(11), 1467–1474. [CrossRef] [Google Scholar]
  • Hofhuis A, van Pelt W, van Duynhoven YT, Nijhuis CD, Mollema L, van der Klis FR, Havelaar AH, Kortbeek LM. 2011. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiology and Infection, 139(4), 530–538. [CrossRef] [PubMed] [Google Scholar]
  • Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. 2007. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. The American Journal of Tropical Medicine and Hygiene, 77(3), 405–410. [CrossRef] [PubMed] [Google Scholar]
  • Khan K, Khan W. 2018. Congenital toxoplasmosis: an overview of the neurological and ocular manifestations. International Journal for Parasitology, 67(6), 715–721. [Google Scholar]
  • Ministero della Sanità. 1998. Decreto Ministeriale 10 settembre 1998. Aggiornamento del decreto ministeriale 6 marzo 1995 concernente l’aggiornamento del decreto ministeriale 14 aprile 1984 recante i protocolli di accesso agli esami di laboratorio e di diagnostica strumentale per le donne in stato di gravidanza ed a tutela della maternità. Rome, Italy. [Google Scholar]
  • Moncada PA, Montoya JG. 2012. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Review of Anti-infective Therapy, 10(7), 815–828. [CrossRef] [PubMed] [Google Scholar]
  • Mosti M, Pinto B, Giromella A, Fabiani S, Cristofani R, Panichi M, Bruschi F. 2013. A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy. Epidemiology and Infection, 141(10), 2192–2195. [CrossRef] [PubMed] [Google Scholar]
  • Nogareda F, Le Strat Y, Villena I, De Valk H, Goulet V. 2014. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation. Epidemiology and Infection, 142(8), 1661–1670. [CrossRef] [PubMed] [Google Scholar]
  • Pinto B, Castagna B, Mattei R, Bruzzi R, Chiumiento L, Cristofani R, Buffolano W, Bruschi F. 2012. Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy. European Journal of Clinical Microbiology & Infectious Diseases, 31(6), 1151–1156. [CrossRef] [Google Scholar]
  • Pinto B, Mattei R, Moscato GA, Cristofano M, Giraldi M, Scarpato R, Buffolano W, Bruschi F. 2017. Toxoplasma infection in individuals in central Italy: does a gender-linked risk exist? European Journal of Clinical Microbiology & Infectious Diseases, 36(4), 739–746. [CrossRef] [Google Scholar]
  • Presidente del Consiglio dei Ministri. 2017. Decreto del Presidente del Consiglio Dei Ministri 12 gennaio 2017. Definizione e aggiornamento dei livelli essenziali di assistenza, di cui all’articolo 1, comma 7, del decreto legislativo 30 dicembre 1992, n. 502. Rome, Italy. [Google Scholar]
  • Puccio G, Cajozzo C, Canduscio LA, Cino L, Romano A, Schimmenti MG, Giuffre M, Corsello G. 2014. Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population. Italian Journal of Pediatrics, 40, 23. [CrossRef] [PubMed] [Google Scholar]
  • Ricci M, Pentimalli H, Thaller R, Rava L, Di Ciommo V. 2003. Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate. Journal of Maternal-Fetal and Neonatal Medicine, 14(6), 398–403. [CrossRef] [Google Scholar]
  • Robert-Gangneux F, Darde ML. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical Microbiology Reviews, 25(2), 264–296. [CrossRef] [PubMed] [Google Scholar]
  • Ruffini E, Compagnoni L, Tubaldi L, Infriccioli G, Vianelli P, Genga R, Bonifazi V, Dieni A, Guerrini D, Basili G, Salvatori P, DeColli R, Leone L, Gesuita R. 2014. Congenital and perinatal infections in the Marche region (Italy): an epidemiological study and differences between ethnic groups. Le Infezioni in Medicina, 22(3), 213–221. [PubMed] [Google Scholar]
  • Stagni L, Romano MA, Romano A, Magli A, Briganti F, Del Pezzo MA, Buffolano W. 2009. Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Memórias do Instituto Oswaldo Cruz, 104(2), 374–377. [CrossRef] [Google Scholar]
  • Tomasoni LR, Sosta E, Beltrame A, Rorato G, Bigoni S, Frusca T, Zanardini C, Driul L, Magrini F, Viale P, Castelli F. 2010. Antenatal screening for mother to child infections in immigrants and residents: the case of toxoplasmosis in northern Italy. Journal of Immigrant and Minority Health, 12(6), 834–840. [CrossRef] [PubMed] [Google Scholar]
  • Tomasoni LR, Meroni V, Bonfanti C, Bollani L, Lanzarini P, Frusca T, Castelli F. 2014. Multidisciplinary approach to congenital Toxoplasma infection: an Italian nationwide survey. New Microbiologica, 37(3), 347–354. [Google Scholar]
  • Valcavi PP, Natali A, Soliani L, Montali S, Dettori G, Cheezi C. 1995. Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy). European Journal of Epidemiology, 11(3), 333–337. [CrossRef] [PubMed] [Google Scholar]